RHOEN-KLINIKUM AG (RHK.DE) Stock Price, Quote, News and Overview
FRA:RHK - Deutsche Boerse Ag - DE0007042301 - Common Stock - Currency: EUR
RHK.DE Quote, Performance and Key Statistics
FRA:RHK (3/7/2025, 7:00:00 PM)
12.9
-0.1 (-0.77%)
The current stock price of RHK.DE is 12.9 EUR. In the past month the price decreased by -8.51%. In the past year, price increased by 2.38%.
RHK.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EMEIS.PA | EMEIS SA | 2.49 | 1.98B | ||
| CLARI.PA | CLARIANE SE | N/A | 1.32B | ||
| GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.15B | ||
| GHC.MI | GAROFALO HEALTH CARE SPA | 13.08 | 448.29M | ||
| M12.DE | M1 KLINIKEN AG | 17.41 | 290.67M | ||
| LNA.PA | LNA SANTE | 11.32 | 283.81M | ||
| MED.DE | MEDICLIN AG | N/A | 136.80M | ||
| LIK.DE | LIMES SCHLOSSKLINIKEN AG | N/A | 83.52M | ||
| EIF.DE | MEDNATION AG | 1.32 | 4.21M |
Related stock screener links
About RHK.DE
Company Profile
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,507 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
Company Info
RHOEN-KLINIKUM AG
Schlossplatz 1
Bad Neustadt an der Saale BAYERN DE
Employees: 18282
Company Website: https://www.rhoen-klinikum-ag.com/
Investor Relations: https://en.rhoen-klinikum-ag.com/investor-relations.html
Phone: 499771650
RHOEN-KLINIKUM AG / RHK.DE FAQ
What is the stock price of RHOEN-KLINIKUM AG today?
The current stock price of RHK.DE is 12.9 EUR. The price decreased by -0.77% in the last trading session.
What is the ticker symbol for RHOEN-KLINIKUM AG stock?
The exchange symbol of RHOEN-KLINIKUM AG is RHK and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is RHK.DE stock listed?
RHK.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for RHOEN-KLINIKUM AG stock?
7 analysts have analysed RHK.DE and the average price target is 13.77 EUR. This implies a price increase of 6.74% is expected in the next year compared to the current price of 12.9. Check the RHOEN-KLINIKUM AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is RHOEN-KLINIKUM AG worth?
RHOEN-KLINIKUM AG (RHK.DE) has a market capitalization of 863.78M EUR. This makes RHK.DE a Small Cap stock.
How many employees does RHOEN-KLINIKUM AG have?
RHOEN-KLINIKUM AG (RHK.DE) currently has 18282 employees.
What are the support and resistance levels for RHOEN-KLINIKUM AG (RHK.DE) stock?
RHOEN-KLINIKUM AG (RHK.DE) has a support level at 12.89 and a resistance level at 13.87. Check the full technical report for a detailed analysis of RHK.DE support and resistance levels.
Is RHOEN-KLINIKUM AG (RHK.DE) expected to grow?
The Revenue of RHOEN-KLINIKUM AG (RHK.DE) is expected to grow by 3.97% in the next year. Check the estimates tab for more information on the RHK.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy RHOEN-KLINIKUM AG (RHK.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RHK.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RHK.DE, evaluating the profitability, health, valuation and growth aspects
- RHOEN-KLINIKUM AG (RHK.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RHOEN-KLINIKUM AG (RHK.DE) Sales and EPS estimates to see what analysts future expectations are.
- RHOEN-KLINIKUM AG (RHK.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RHOEN-KLINIKUM AG (RHK.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- RHOEN-KLINIKUM AG (RHK.DE) Stock Chart to make your own analysis
- RHOEN-KLINIKUM AG (RHK.DE) Latest news and press-releases to stay up to date.
Does RHOEN-KLINIKUM AG (RHK.DE) stock pay dividends?
RHOEN-KLINIKUM AG (RHK.DE) has a dividend yield of 1.38%. The yearly dividend amount is currently 0.15. Check the full fundamental report for a detailed analysis of RHK.DE dividend history, reliability and sustainability.
When does RHOEN-KLINIKUM AG (RHK.DE) report earnings?
RHOEN-KLINIKUM AG (RHK.DE) will report earnings on 2025-03-27, after the market close.
What is the Price/Earnings (PE) ratio of RHOEN-KLINIKUM AG (RHK.DE)?
The PE ratio for RHOEN-KLINIKUM AG (RHK.DE) is 19.25. This is based on the reported non-GAAP earnings per share of 0.67 and the current share price of 12.9 EUR. Check the full fundamental report for a full analysis of the valuation metrics for RHK.DE.
RHK.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to RHK.DE. When comparing the yearly performance of all stocks, RHK.DE turns out to be only a medium performer in the overall market: it outperformed 52.94% of all stocks.
RHK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to RHK.DE. RHK.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
RHK.DE Financial Highlights
Over the last trailing twelve months RHK.DE reported a non-GAAP Earnings per Share(EPS) of 0.67. The EPS increased by 36.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.08% | ||
| ROA | 2.56% | ||
| ROE | 3.66% | ||
| Debt/Equity | 0.11 |
RHK.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to RHK.DE. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 40.91% and a revenue growth 3.97% for RHK.DE